Italy Lithium Neutron Capture Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Monotherapy, Combination Therapy), By Application (Brain Tumors, Head and Neck Cancers, Others), By End-User (Hospitals with Advanced Radiotherapy Units, Research Institutes, Specialty Cancer Centers) and Forecasts, 2025-2033

Italy Lithium Neutron Capture Therapy Market Insights

Italy’s Li-NCT market is witnessing growing academic and institutional interest, particularly from oncology research centers in Milan, Rome, and Bologna. The country’s focus on personalized cancer treatment and increasing collaboration with EU nuclear research programs is a key driver. However, one of the major restraints is the slow pace of regulatory reform for advanced neutron-based therapies, which often delays pilot studies and technology deployment. The trend of integrating theranostics (therapy + diagnostics) is opening new frontiers, especially for glioblastoma and head-neck tumors. As Italy continues to modernize its radiotherapy infrastructure, lithium-based neutron therapies are being positioned as a next-gen modality, particularly for rare or radiation-resistant tumors. Opportunities are also expanding due to growing EU funding for cross-border proton and neutron therapy facilities. Nevertheless, challenges remain in workforce training and nuclear logistics. The Italian Li-NCT market is projected to grow at a CAGR of around 13.2% over the next five years.